Cargando…

Stability and In Vitro Aerodynamic Studies of Inhalation Powders Containing Ciprofloxacin Hydrochloride Applying Different DPI Capsule Types

In the case of capsule-based dry powder inhalation systems (DPIs), the selection of the appropriate capsule is important. The use of gelatin, gelatin-PEG, and HPMC capsules has become widespread in marketed capsule-based DPIs. We aimed to perform a stability test according to the ICH guideline in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benke, Edit, Varga, Patrícia, Szabó-Révész, Piroska, Ambrus, Rita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151261/ https://www.ncbi.nlm.nih.gov/pubmed/34064698 http://dx.doi.org/10.3390/pharmaceutics13050689

Ejemplares similares

The effect of ethanol on the habit and in vitro aerodynamic results of dry powder inhalation formulations containing ciprofloxacin hydrochloride
por: Benke, Edit, et al.
Publicado: (2021)

Development of an Innovative, Carrier-Based Dry Powder Inhalation Formulation Containing Spray-Dried Meloxicam Potassium to Improve the In Vitro and In Silico Aerodynamic Properties
por: Benke, Edit, et al.
Publicado: (2020)

Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach
por: Karimi, Keyhaneh, et al.
Publicado: (2016)

Formulation and In Vitro and In Silico Characterization of “Nano-in-Micro” Dry Powder Inhalers Containing Meloxicam
por: Party, Petra, et al.
Publicado: (2021)

The Development of an In Vitro Horizontal Diffusion Cell to Monitor Nasal Powder Penetration Inline
por: Gieszinger, Péter, et al.
Publicado: (2021)

Investigation of Physico-Chemical Stability and Aerodynamic Properties of Novel “Nano-in-Micro” Structured Dry Powder Inhaler System
por: Party, Petra, et al.
Publicado: (2023)

In Vitro Drug Release, Permeability, and Structural Test of Ciprofloxacin-Loaded Nanofibers
por: Uhljar, Luca Éva, et al.
Publicado: (2021)

Preliminary study of nanonized lamotrigine containing products for nasal powder formulation
por: Gieszinger, Péter, et al.
Publicado: (2017)

Physico-Chemical and In Vitro Characterization of Chitosan-Based Microspheres Intended for Nasal Administration
por: Bartos, Csilla, et al.
Publicado: (2021)

Aronia Berry Processing by Spray Drying: From Byproduct to High Quality Functional Powder
por: Vidović, Senka, et al.
Publicado: (2019)

Development of Solvent-Free Co-Ground Method to Produce Terbinafine Hydrochloride Cyclodextrin Binary Systems; Structural and In Vitro Characterizations
por: Kondoros, Balázs Attila, et al.
Publicado: (2022)

Comparison of Modern In Vitro Permeability Methods with the Aim of Investigation Nasal Dosage Forms
por: Bartos, Csilla, et al.
Publicado: (2021)

Preparation and Characterization of Ibuprofen Containing Nano-Embedded-Microparticles for Pulmonary Delivery
por: Party, Petra, et al.
Publicado: (2023)

Investigation of the Absorption of Nanosized lamotrigine Containing Nasal Powder via the Nasal Cavity
por: Ambrus, Rita, et al.
Publicado: (2020)

Discrete Element Method Evaluation of Triboelectric Charging Due to Powder Handling in the Capsule of a DPI
por: Alfano, Francesca Orsola, et al.
Publicado: (2023)

Spray Drying of a Subcritical Extract Using Marrubium vulgare as a Method of Choice for Obtaining High Quality Powder
por: Gavarić, Aleksandra, et al.
Publicado: (2019)

Ciprofloxacin dry powder inhaler in cystic fibrosis
por: Elborn, J Stuart
Publicado: (2016)

Comparative Assessment of In Vitro and In Silico Methods for Aerodynamic Characterization of Powders for Inhalation
por: Ignjatović, Jelisaveta, et al.
Publicado: (2021)

Comparison of HPMC Inhalation-Grade Capsules and Their Effect on Aerosol Performance Using Budesonide and Rifampicin DPI Formulations
por: Ding, Li, et al.
Publicado: (2022)

Characterizing the Drug-Release Enhancement Effect of Surfactants on Megestrol-Acetate-Loaded Granules
por: Katona, Gábor, et al.
Publicado: (2022)

Smartcrystals for Efficient Dissolution of Poorly Water-Soluble Meloxicam
por: Ambrus, Rita, et al.
Publicado: (2022)

Preference for Easyhaler(®) Over Previous Dry Powder Inhalers in Asthma Patients: Results of the DPI PREFER Observational Study
por: Alvarez-Gutiérrez, Francisco Javier, et al.
Publicado: (2021)

Physico-Chemical, In Vitro and Ex Vivo Characterization of Meloxicam Potassium-Cyclodextrin Nanospheres
por: Varga, Patrícia, et al.
Publicado: (2021)

Understanding the Importance of Capsules in Dry Powder Inhalers
por: Buttini, Francesca, et al.
Publicado: (2021)

Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study
por: Schuster, Antje, et al.
Publicado: (2013)

Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler(®) in Comparison with Diskus(®) and Turbohaler(®) Dry Powder Inhalers
por: Buttini, Francesca, et al.
Publicado: (2016)

Simple Method to Measure the Aerodynamic Size Distribution of Porous Particles Generated on Lyophilizate for Dry Powder Inhalation
por: Miyamoto, Kahori, et al.
Publicado: (2020)

The Effect of an Optimized Wet Milling Technology on the Crystallinity, Morphology and Dissolution Properties of Micro- and Nanonized Meloxicam
por: Bartos, Csilla, et al.
Publicado: (2016)

Improvement of Inhalation Profile of DPI Formulations by Carrier Treatment with Magnesium Stearate
por: Hazare, Shruti, et al.
Publicado: (2009)

BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension
por: Spikes, Leslie A., et al.
Publicado: (2022)

Enhancing bioavailability of natural extracts for nutritional applications through dry powder inhalers (DPI) spray drying: technological advancements and future directions
por: Wang, Bo, et al.
Publicado: (2023)

Ciprofloxacin DPI: a randomised, placebo-controlled, phase IIb efficacy and safety study on cystic fibrosis
por: Dorkin, Henry L, et al.
Publicado: (2015)

The Effect of Particle Size and Surface Roughness of Spray-Dried Bosentan Microparticles on Aerodynamic Performance for Dry Powder Inhalation
por: Kwon, Yong-Bin, et al.
Publicado: (2020)

Recent advances in capsule-based dry powder inhaler technology
por: Lavorini, Federico, et al.
Publicado: (2017)

Development and characterization of in-situ gel for ophthalmic formulation containing ciprofloxacin hydrochloride
por: Makwana, S.B., et al.
Publicado: (2015)

Inhalable Nano-Dimpled Microspheres Containing Budesonide-PLGA for Improved Aerodynamic Performance
por: Han, Chang-Soo, et al.
Publicado: (2022)

Preparation, Statistical Optimization and In-vitro Characterization of a Dry Powder Inhaler (DPI) Containing Solid Lipid Nanoparticles Encapsulating Amphotericin B: Ion Paired Complexes with Distearoyl Phosphatidylglycerol
por: Mehrabani Yeganeh, Ehsan, et al.
Publicado: (2020)

Inhalation of a Dry Powder Ciprofloxacin Formulation in Healthy Subjects: A Phase I Study
por: Stass, Heino, et al.
Publicado: (2013)

Erratum to: Recent advances in capsule-based dry powder inhaler technology
por: Lavorini, Federico, et al.
Publicado: (2017)

A Quality by Design Framework for Capsule-Based Dry Powder Inhalers
por: Ding, Li, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1h3vnapm02g7edbrrbr96efikb